2023 Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia-a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Giuliano Filippini Velázquez Journal Bone Marrow Transplant.
2023 Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Bone Marrow Transplant.
2023 Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Klaus Hirschbühl Journal Bone Marrow Transplant.
2023 Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Group Cellular Therapy & Immunobiology Working Party (CTIWP) Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal J Immunother Cancer.
2023 A guide to the collection of T-cells by apheresis for ATMP manufacturing-recommendations of the GoCART coalition apheresis working group Group GoCART Coalition 1st listed author Nina Worel Journal Bone Marrow Transplant.
2023 Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Iman Abou Dalle Journal Bone Marrow Transplant.
2023 Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Raynier Devillier Journal Haematologica.
2023 Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Gesine Bug Journal Bone Marrow Transplant.
2023 Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases Group Autoimmune Diseases Working Party (ADWP) Infectious Diseases Working Party (IDWP) 1st listed author Raffaella Greco Journal J Autoimmun.
2023 Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry Group Infectious Diseases Working Party (IDWP) 1st listed author Per Ljungman Journal Front Immunol.
2023 Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation Group Autoimmune Diseases Working Party (ADWP) 1st listed author Alessandro Bruno Journal J Allergy Clin Immunol.
2023 Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal J Hematol Oncol.